Pretzel Therapeutics

Pretzel Therapeutics is a company headquartered in the United States. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.

Pretzel Therapeutics is dedicated to developing life-changing medicines with a broad pipeline of first-in-class treatments addressing novel targets within the mitochondria, the primary organelles responsible for producing and regulating cellular energy. By harnessing cellular energetics, they are ushering in a new treatment paradigm for a range of conditions spanning neurological, muscular atrophies, metabolic and rare diseases.